Biomedical Science Center, Korea Institute of Science and Technology, 39-1 Hawolgok-dong, Seongbuk-gu, Seoul 136-791, Korea.
Small. 2011 Jan 3;7(1):112-8. doi: 10.1002/smll.201001358.
A new type of heavy-atom-affected Pluronic (F-127) nanoparticle (FIC NP) for photodynamic therapy (PDT) is reported. FIC NPs are formulated with biocompatible constituents, and contain densely integrated iodinated aromatic molecules that form a structurally rigid core matrix and stably encapsulate photosensitizers in a monomeric form. Tiny nanoparticles (≈10 nm) are prepared by aqueous dispersion of photosensitizer-embedded aromatic nanodomains, which self-assemble by phase separation from the Pluronic melt mixture. By using spectroscopic studies and cellular experiments, the following is demonstrated: 1) enhanced singlet-oxygen generation by means of the intraparticle heavy-atom effect on the embedded photosensitizer, 2) facilitated cell uptake due to the small nanoscopic size as well as the Pluronic surface characteristics, and thereby 3) actual enhancement of PDT efficacy for a human breast-cancer cell line (MDA-MB-231), which validates a photophysically motivated nanoformulation approach toward an advanced photosensitizing nanomedicine.
一种新型的重原子影响的泊洛沙姆(F-127)纳米颗粒(FIC NP)用于光动力疗法(PDT)。FIC NPs 由生物相容性成分组成,包含密集整合的碘化芳族分子,形成结构刚性的核心基质,并以单体形式稳定地包封光敏剂。通过将相分离自泊洛沙姆熔体混合物的嵌入芳族纳米域的光敏剂的水性分散体来制备微小的纳米颗粒(≈10nm)。通过光谱研究和细胞实验证明:1)通过嵌入光敏剂的粒子内重原子效应增强单线态氧的生成,2)由于纳米尺寸以及泊洛沙姆表面特性,促进细胞摄取,从而 3)实际增强了人乳腺癌细胞系(MDA-MB-231)的 PDT 疗效,验证了一种基于光物理的纳米制剂方法,用于先进的光敏纳米医学。